Nasopharynx administration of mupirocin for prophylactic treatment of recurrent otitis media
US6001870A · kind A · utility
19Cited by
4References
4Claims
0Family size
Assignees
Inventor
Key dates
| Filing date | Sep 30, 1997 |
| Grant date | Dec 14, 1999 |
| Priority date | — |
| Expiry date | Sep 30, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Mupirocin or a salt or ester thereof may be used to treat recurrent sinusitis and recurrent otitis, in particular with novel spray or cream formulations adapted for administration to the nasopharynx.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.